ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages

Wu, Siyuan; Lv, Xiaozhi; Wei, Haigang; Chen, Wuya; Zheng, Junming; Li, Xia; Song, Jing; Ai, Yilong*; Zou, Chen佛山科学技术学院; 南方医科大学
Journal of Cellular and Molecular Medicine2023-12DOI: 10.1111/jcmm.17998
10阅读
引用收藏
分享

摘要

Cisplatin (CDDP) chemoresistance is one of the predominant factors in oral squamous cell carcinoma (OSCC) treatment failure. Uncovering the mechanisms underlying CDDP resistance is of great importance in OSCC therapy. Circular RNAs (circRNAs) are a newly discovered class of noncoding RNAs, which are reported to participate in the progression of various diseases, including cancer. However, the function of circRNAs in CDDP resistance in OSCC remains unclear. Quantitative reverse transcription PCR was used to search for different circRNAs between OSCC cell lines and CDDP-resistant cell lines. The results showed that circ-ILF2 expression was higher in CDDP-resistant OSCC cell lines. The stability of circ-ILF2 was also confirmed using RNase R and actinomycin D assays. Functional experiments, including cytotoxicity, apoptosis and growth rate assays, showed that upregulation of circ-ILF2 contributes to CDDP resistance. Luciferase reporter-gene, RNA pull-down and quantitative real-time PCR (RT-qPCR) assays showed that circ-ILF2 functions as a microRNA sponge for miR-1252. Luciferase reporter assays, RNA pull-down, RT-qPCR and Western blotting showed that miR-1252 directly targeted and regulated the expression of KLF8. Circ-ILF2 plays an important role in CDDP resistance in OSCC. Circ-ILF2 exerts its function through the miR-1252/KLF8 pathway. In addition, tumour-associated macrophages (TAM) play important roles in cancer progressions, our results showed that circ-ILF2 in OSCC cells induced the M2 polarization of macrophages which provided new thoughts on immunotherapy. Our results suggest that circ-ILF2 may represent a potential therapeutic target in CDDP-resistant OSCC.

学科与关键词

关键词
circ-ILF2cisplatin resistanceM2 polarization of macrophagesoral squamous cell carcinoma
相关
加载中…
  • SP2-induced circPUM1 modulates chemoresistance and nature killer cell toxicity in oral squamous cell carcinoma
    Liu, Lian; Zou, Chen; Lv, Xiaozhi; Wei, Haigang; Wu, Siyuan; Song, Jing; Tang, Zhe; Luo, Hailing; Li, Xia*; Ai, Yilong*Journal of Cellular and Molecular Medicine, 2023.
  • circ_0001461 promotes oral squamous cell carcinoma progression through miR-145/TLR4/NF-kB axis
    Ai, Yilong; Song, Jing; Wei, Haigang; Tang, Zhe; Li, Xia; Lv, Xiaozhi; Luo, Hailing; Wu, Siyuan*; Zou, Chen*Biochemical and Biophysical Research Communications, 2021, 566: 108-114.被引 13
  • Circular GOLPH3 RNA exerts oncogenic effects in vitro by regulating the miRNA-1299/LIF axis in oral squamous cell carcinoma
    Zou, Chen; Li, Xia; Wei, Haigang; Wu, Siyuan; Song, Jing; Tang, Zhe; Luo, Hailing; Lv, Xiaozhi*; Ai, YilongBioengineered, 2022, 13(4): 11012-11025.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cellular and Molecular Medicine
发表日期
2023-12
卷期
第 27 卷, 第 24 期
页码
4133-4144
DOI
10.1111/jcmm.17998
语言
ENGLISH
成果收录
SCIE
资助标注
Guangdong Basic and Applied Basic Research Foundation [2022A1515140098]; Guangdong Basic and Applied Basic Research Foundation [2022A1515140098]

作者

  • W

    Wu, Siyuan (第一作者)

    foshan univ

  • L

    Lv, Xiaozhi

    southern med univ

查看全部 9 位作者收起作者
  • W

    Wei, Haigang

    foshan univ

  • C

    Chen, Wuya

    foshan univ

  • Z

    Zheng, Junming

    foshan univ

  • L

    Li, Xia

    foshan univ

  • S

    Song, Jing

    foshan univ

  • A

    Ai, Yilong (通讯)

    foshan univ

  • Z

    Zou, Chen

    foshan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417